Learn which sexual changes are linked to low testosterone, why erection problems need context and how to describe symptoms at a medical visit.
Which changes deserve a closer look? Reduced sexual desire, fewer spontaneous or morning erections and erectile difficulties deserve discussion with a clinician, according to European Association of Urology (EAU) guidance.
This article is for informational purposes only and is not medical advice. Decisions about individual symptoms and testing belong with a qualified clinician.
EAU guidance on male hypogonadism identifies reduced libido, erectile dysfunction and fewer spontaneous or morning erections as relatively specific symptoms associated with late-onset hypogonadism (LOH). It describes sexual symptoms as the most specific symptom group associated with LOH.
That makes a change in sexual desire or erection patterns relevant to a hormone discussion. It also makes precision useful: lower interest in sex is a different description from an erection that is less firm or does not last as long.
A useful starting point is to separate the concern into distinct questions:
These questions organize a conversation. The aim is to explain the change rather than collapse every sexual concern into the phrase “low testosterone.”
Libido means sexual desire. In the EAU’s sexual-history framework, desire is discussed alongside arousal and other aspects of sexual function rather than being treated as a substitute for them.
An account of lower desire can focus on what feels different from the earlier pattern. Has interest itself changed? Or is the main concern erection quality during sexual activity? If both have changed, describing them separately preserves useful detail.
The distinction also helps make an appointment more specific. Saying that interest in sex has fallen gives a different starting point from saying that erections have become less firm despite an unchanged desire for sex.
Keeping sexual interest separate from erection problems gives the conversation a clearer focus. Both concerns deserve to be heard without requiring the reader to decide which explanation fits before the appointment.
EAU erectile-dysfunction guidance recommends discussing both morning erections and erections during sexual stimulation. It also recommends describing rigidity and duration.
Those are separate pieces of information:
A statement such as “my erections have changed” leaves these details unclear. A fuller description explains whether the issue concerns frequency, firmness or duration.
Morning erections and erections during stimulation each deserve their own description. If the change is noticeable in one setting but not the other, that difference belongs in the account. The purpose is to give the clinician the separate features that the EAU includes in a detailed sexual history.
No. EAU guidance describes vascular and hormonal contributors to erectile dysfunction. It also includes neurological or anatomical causes alongside medication-related and psychological factors.
Chronic health conditions and other risk factors are relevant too. This is why erection difficulties call for a broader medical assessment rather than an automatic testosterone explanation.
The practical distinction is between noticing a symptom and choosing its cause. Reporting weaker erections is useful clinical information. Describing them as “a testosterone problem” assigns an explanation before the assessment has taken place.
In a medical conversation, erection quality belongs alongside sexual desire and the other details of the sexual history. Keeping the description open allows a clinician to consider the range of contributors identified in the guideline without dismissing the sexual concern.
Yes. EAU guidance recommends asking about ejaculation and orgasm as part of a detailed sexual history. Its male hypogonadism guidance also lists delayed ejaculation and reduced frequency of intercourse or masturbation as less specific symptoms of LOH.
These details are still worth describing. Their lower specificity gives them a different place in the assessment from the more characteristic sexual symptom group. It does not mean they should be left out of the conversation.
A useful account keeps the different parts of sexual function separate:
This gives the clinician a clearer account than describing everything as reduced sexual performance. In particular, a change in how often sexual activity occurs should not stand in for a description of what has changed during it.
A practical history can describe when a change began, whether it has been steady or intermittent and how it has developed. This is a way to organize the detailed sexual history recommended by the EAU, not a formal diagnostic rule.
If different symptoms began at different times, that distinction belongs in the account. For example, a change in desire and a change in morning erection frequency do not need to be presented as a single event when they were noticed separately.
A short set of notes can focus on:
The purpose is an accurate account rather than a perfect record. Details that are uncertain can remain uncertain instead of being turned into an exact date or a presumed cause.
The EAU’s erectile-dysfunction guidance identifies chronic health conditions and some medications as relevant to assessment. A medical history therefore gives context to the sexual history.
Relevant information includes existing health conditions and the medicines being taken. If a symptom appeared around the time a medicine or health situation changed, that timing is worth describing without treating it as proof of a connection.
An appointment is a place to discuss those questions with the prescribing or evaluating clinician. The role of the history is to make potentially relevant information visible, not to assign responsibility to a medicine based on timing alone.
More background on possible hormonal and sexual effects of medicines can help distinguish a medication question from an established explanation. A clear account leaves room for the clinician to assess that distinction.
The EAU requires compatible symptoms or signs together with consistently low testosterone for a diagnosis of LOH. Neither a symptom checklist nor an isolated low laboratory result establishes that pattern.
Its guidance recommends early-morning, fasting total testosterone measurement. When testosterone is low, the EAU recommends repeat measurements on at least two separate occasions before testosterone therapy.
A physician or endocrinologist can bring the parts of the history together: sexual desire, erection characteristics and other aspects of sexual function. Health conditions and medication history supply additional context for that review.
This is why understanding the role of repeat hormone testing matters alongside a clear symptom account. Testing addresses the hormone measurement; the history explains what is happening clinically. Both contribute to the overall assessment rather than competing as alternative ways to reach a conclusion.
The immediate aim is a specific account of what has changed. Reduced desire and changes in morning erections deserve attention alongside erection quality and other sexual concerns. A clinician can then assess those details within the broader medical history and the EAU’s diagnostic framework.
How might future research refine which combinations of sexual symptoms are most useful for deciding when testosterone evaluation is warranted?
Once sexual changes have been described, the next task is framing questions for medical review, a step supported by Testostra’s coverage of testosterone and male hormonal health. Its evidence-led explanations address uncertainty about possible causes and the meaning of hormone testing, helping readers approach that conversation without treating educational material as an individual diagnosis.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra